Eli Lilly and Company, commonly known as Lilly, is a leading American multinational pharmaceutical company founded in 1876 by Eli Lilly, a pharmaceutical chemist and Civil War veteran. Headquartered in Indianapolis, Indiana, Lilly operates offices in 18 countries and its products are marketed in approximately 125 countries worldwide. It is recognized as one of the largest and most valuable drug companies globally, with a market capitalization reaching $842 billion as of October 2024, marking the highest valuation ever achieved by a pharmaceutical firm.
Lilly’s portfolio is widely known for its significant contributions to mental health and diabetes care. The company developed and markets clinical depression treatments such as Prozac (fluoxetine), introduced in 1986, Cymbalta (duloxetine) from 2004, and the antipsychotic medication Zyprexa (olanzapine), launched in 1996. Additionally, Lilly excels in diabetes treatment with flagship products like Humalog (insulin lispro) introduced in 1996 and Trulicity (dulaglutide) from 2014.
Financially, Lilly ranks 127th on the Fortune 500 list with reported revenues of $34.12 billion. The company is also placed on the Forbes Global 2000 list, underscoring its prominence among the largest publicly traded companies worldwide, and is ranked 252nd on Forbes’ list of America’s Best Employers.
Lilly’s dedication to innovation in pharmaceutical research and global healthcare access defines its mission to improve health outcomes. Its longstanding history, combined with robust research and development, supports its status as a trusted leader in the pharmaceutical industry.
The company’s corporate headquarters is at the Lilly Corporate Center in Indianapolis, maintaining a central role in its operational and strategic activities globally. With a commitment to pioneering medical advancements, Lilly continues to influence healthcare standards and patient care across multiple therapeutic areas.